SCHEMBL18406895

SCHEMBL18406895

O=C(/C=C/C(=O)OC[C@H](NS(=O)(=O)c1ccccc1)c1ccccc1)OC[C@H](NS(=O)(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ EEF2K O00418 3/20 0.48
▸ PRKCG P05129 1/20 0.46
▸ PRKCB P05771 1/20 0.46
▸ PRKCD Q05655 1/20 0.46
▸ CTSL P07711 1/20 0.43
▸ CTSS P25774 1/20 0.43
▸ CYP1A2 P05177 2/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ TSHR P16473 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ SLC1A3 P43003 2/20 0.41
▸ SLC1A2 P43004 2/20 0.41
▸ SLC1A1 P43005 2/20 0.41
▸ MDM4 O15151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18406903 1.00 ALDH1A1 (0.49) ALDH1A1ATML3MBTL1EEF2KPRKCG
SCHEMBL18405685 0.95 ALDH1A1 (0.48) ALDH1A1ATML3MBTL1EEF2KPRKCG
SCHEMBL18405702 0.94 MAPT (0.51) ALDH1A1ATML3MBTL1EEF2KPRKCG
SCHEMBL18405703 0.92 ALDH1A1 (0.46) ALDH1A1ATML3MBTL1EEF2KPRKCG
SCHEMBL18406911 0.84 MAPT (0.45) ALDH1A1ATML3MBTL1EEF2KCYP1A2
SCHEMBL18406900 0.84 MAPT (0.45) ALDH1A1ATML3MBTL1EEF2KCYP1A2
SCHEMBL18406909 0.83 MAPT (0.47) ALDH1A1ATML3MBTL1LMNAKMT2A
SCHEMBL18406901 0.83 MAPT (0.47) ALDH1A1ATML3MBTL1LMNAKMT2A
SCHEMBL18406862 0.83 SMN1; SMN2 (0.55) ALDH1A1L3MBTL1CYP1A2CYP2C9CYP2C19
SCHEMBL18406868 0.83 SMN1; SMN2 (0.55) ALDH1A1L3MBTL1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170022153-A1 FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE Nguyen, Mark Quang (US) 2017-01-26 — — US disclosed
US-20170022153-A1 FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE Nguyen, Mark Quang (US) 2017-01-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170022153-A1 FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE FH, FPGS, APC ALDH1A1 1949/4885ATM 4406/4885L3MBTL1 4164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback